Summary
In a single blind crossover study, ciclazindol, 10-(m-chlorophenyl)-2, 3, 4, 10-tetrahydropyrimide (1, 2α) indol-10-ol hydrochloride (Fig. 1), has been found to have hypoglycaemic action, and to produce reduction in appetite and weight. The mode of action appears to be different from either biguanides or sulphonylureas. Side-effects were few and mild. Metformin 500 mg b.d. had comparable hypoglycaemic effect but did not suppress appetite. Ciclazindol may be useful as a mild oral hypoglycaemic agent for obese patients, and would be suitable for once daily administration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kirby MJ, Williams PJ (1978) The effect of propranolol and other antagonists on ciclazindol-induced glucose uptake into the isolated rat hemi-diaphragm. Proc. 7th International Congress of Pharmacology, Paris. Boissier JR (ed), 1979. Pergamon London, p 268. Abstract no 686
Kirby MJ, Turner P (1977) Ciclazindol and mazindol on glucose uptake into human isolated skeletal muscle: No interaction of mazindol with methysergide. Br J Clin Pharmacol 4: 459–461
Sirtori C, Hurwitz A, Azarnoff DL (1971) Hyperinsulinemia secondary to chronic administration of mazindol and d-amphetamine. Am J Med Sci 261: 341–349
Ehzanullah RSB, Kirby MJ, Leighton M, Oh VMS (1977) Some clinical pharmacological studies with ciclazindol hydrochloride. Br J Clin Pharmacol 4: 400
Swaisland AJ, Franklin RA, Southgate PJ, Coleman AJ (1977) The pharmacokinetics of ciclazindol in human volunteers. Br J Clin Pharmacol 4: 61–65
Waterfall JF, Smith MA, Gaston WH, Maher J, Warburton G (1979) Cardiovascular and autonomic actions of ciclazindol and tricyclic antidepressants. Archives internationales de Pharmacodynamie et de Thérapie 240 [1]: 116–136
Beckett PR, Southgate PJ, Sugden RF (1973) The pharmacology of WY 23409: A new antidepressant. Naunyn-Schmiedebergs Arch Pharmacol 279 [Suppl]: p R-27. Abstract no 41
Ghose K, Rama Rao VA, Bailey J, Coppen A (1978) Antidepressant activity and pharmacological interactions of ciclazindol. Psychopharmacology 57: 109–114
Chart EM, Fletcher A, Wyllie MG (1982) The underlying mechanism of ciclazindol-induced weight loss in rats. Br J Pharmacol 75: 111P
Rothwell NJ, Stock MJ, Wyllie MG (1981) Sympathetic mechanisms in diet-induced thermogenesis; modification by ciclazindol and anorectic drugs. Br J Pharmacol 74: 539–546
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lean, M.E.J., Borthwick, L.J. Ciclazindol: An oral agent with weight reducing properties and hypoglycaemic activity. Eur J Clin Pharmacol 25, 41–45 (1983). https://doi.org/10.1007/BF00544012
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00544012